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Abstract
Retinitis pigmentosa (RP) is a highly heterogeneous genetic disease including autosomal recessive (ar), autosomal dominant
(ad), and X-linked inheritance. Recently, arRP has been associated with mutations in EYS (Eyes shut homolog), which is a
major causative gene for this disease. This study was conducted to determine the spectrum and frequency of EYS mutations
in 100 Japanese arRP patients. To determine the prevalence of EYS mutations, all EYS exons were screened for mutations by
polymerase chain reaction amplification, and sequence analysis was performed. We detected 67 sequence alterations in EYS,
of which 21 were novel. Of these, 7 were very likely pathogenic mutations, 6 were possible pathogenic mutations, and 54
were predicted non-pathogenic sequence alterations. The minimum observed prevalence of distinct EYS mutations in our
study was 18% (18/100, comprising 9 patients with 2 very likely pathogenic mutations and the remaining 9 with only one
such mutation). Among these mutations, 2 novel truncating mutations, c.4957_4958insA (p.S1653KfsX2) and c.8868C.A
(p.Y2956X), were identified in 16 patients and accounted for 57.1% (20/35 alleles) of the mutated alleles. Although these 2
truncating mutations were not detected in Japanese patients with adRP or Leber’s congenital amaurosis, we detected them
in Korean arRP patients. Similar to Japanese arRP results, the c.4957_4958insA mutation was more frequently detected than
the c.8868C.A mutation. The 18% estimated prevalence of very likely pathogenic mutations in our study suggests a major
involvement of EYS in the pathogenesis of arRP in the Japanese population. Mutation spectrum of EYS in 100 Japanese
patients, including 13 distinct very likely and possible pathogenic mutations, was largely different from the previously
reported spectrum in patients from non-Asian populations. Screening for c.4957_4958insA and c.8868C.A mutations in the
EYS gene may therefore be very effective for the genetic testing and counseling of RP patients in Japan.
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Introduction
Retinitis pigmentosa (RP [MIM 268000]) is a highly heteroge-
neous genetic disease characterized by night blindness and visual
field constriction leading to severe visual impairment. The disease
appears with different modes of inheritance including autosomal
recessive (ar), autosomal dominant (ad), and X-linked, and
currently over half of cases are isolated in Japan.
To date, 53 causative genes and 7 loci of RP have been
identified (http://www.sph.uth.tmc.edu/Retnet/), including the
eyes shut homolog (EYS) gene encoding an ortholog of Drosophila
spacemaker (spam), a protein essential for photoreceptor
morphology. EYS spans over 2 Mb, making it one of the largest
known genes expressed in the human eye [1,2]. EYS gene
mutations, primarily truncating and some missense mutations,
have been detected in arRP families of different ancestral origin
and have reported to account for 5–16% of arRP [3–6]. Most
gene mutations (e.g., RHO, PRPH2, PRPF31, RP1,a n d
IMPDH1) have been found in Japanese patients with adRP,
with few reports describing mutations in arRP [7,8]. Therefore,
the genes causing arRP in most Japanese families have yet to be
identified.
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31036In this study, we screened all EYS gene exons in 100 unrelated
Japanese RP patients. We found 2 novel truncating EYS gene
mutations that were surprisingly related to 16% of Japanese arRP
patients, but were not detected in Japanese patients with either
adRP or Leber’s congenital amaurosis (LCA [MIM204000], the
earliest onset and most severe form of hereditary retinal dystrophy
with several clinical features overlapping with those of RP).
Additionally, these mutations were also detected in 9% of Korean
arRP patients.
Methods
Patients and clinical evaluation
We screened all EYS gene exons in 100 unrelated Japanese RP
patients with no systemic manifestations, excluding families with
obvious autosomal dominant inheritance. Some pedigrees showed
a pattern compatible with the recessive mode of inheritance; the
other patients were considered isolated cases. In addition, 200
unrelated and non-RP Japanese individuals were screened as
controls to evaluate the frequency of the mutations found in the
patient samples. We also screened a part of EYS gene exons 26 and
44 in 19 unrelated Japanese adRP patients, 28 unrelated Japanese
LCA patients, and 32 unrelated Korean arRP patients. The 19
Japanese adRP patients had already been screened for some
principal adRP-causing genes, but the pathogenic mutations have
not yet been detected. Examples of the screening list for adRP-
causing genes and targeted exons include exon 3 and 4 in RP1;
exon 1, 2, 3, 4, and 5 in RHO; exon 1, 2, and 3 in PRPH2; exon 2,
3, and 4 in CRX; exon 11 in PRPF3; exon 10, 11, and 12 in
IMPDH1; exon 2 in NRL; exon 43 in PRPF8; exon 1 and 2
in ROM1; exon 5 and 6 in RP9; exon 2, 3, 5, 6, 7, 8, 11, and 12 in
PRPF31; exon 11 and 15 in SEMA4A; exon 1 in CA4; exon 3 in
GUCA1B; exon 3 in SP4; and exon 3 in TOPORS.
Japanese RP patients were examined either at the Department
of Ophthalmology, Hamamatsu University Hospital in Hama-
matsu (by YH), Department of Ophthalmology, Kobe City
Medical Center General Hospital in Kobe (by MT), or
Department of Ophthalmology, Nagoya University Hospital in
Nagoya (by MK). Patients’ origin varied widely, from the Tokyo to
Osaka areas in Japan. Japanese LCA patients were examined at
the Department of Ophthalmology and Laboratory of Cell
Biology, National Center for Child Health and Development in
Tokyo (by NA). LCA patients’ origin varied widely, from all over
Japan except the Okinawa islands. Meanwhile, Korean RP
patients were examined at the Department of Ophthalmology,
Kyungpook National University Hospital in Daegu (by ITK). The
Korean patients’ origin varied widely, from Daegu to Yeongju and
Pohang areas in Gyeongsangbuk-do, Korea. A full ophthalmic
examination was performed. Clinical diagnosis for RP was based
on visual field, fundus examination, and electroretinogram
findings, and clinical diagnosis for LCA was based on fundus
examination and electroretinogram findings.
Ethics statements
This study was approved by the Institutional Review Board for
Human Genetic and Genome Research at the 6 participating
institutions (Hamamatsu University School of Medicine, RIKEN
Center for Developmental Biology, Nagoya University Graduate
School of Medicine, National Center for Child Health and
Development, Chiba University Graduate School of Medicine,
and Kyungpook National University Hospital), and its procedures
conformed to the tenets of the Declaration of Helsinki. Written
informed consent was obtained from all participants before
molecular genetic studies.
Mutation analysis
Genomic DNA in Japanese samples was extracted from the
peripheral lymphocytes using standard procedures. In Korean
samples, whole blood samples were collected on FTA cards (GE
Healthcare). Blood samples were spotted onto the cards and air-
dried for 1 h at room temperature. For polymerase chain reaction
(PCR) amplification, a 1.2-mm disk was punched from a dried
blood spot using a Harris micro-punch tool (GE Healthcare) and
processed according to the manufacturer’s instructions. PCR was
performed using the KOD -Plus- ver. 2 PCR kit (Toyobo) with the
primer sets described in Table S1 for 35 cycles of 98uC for 10 s,
60uC for 30 s, and 68uC for 1 min in an automated thermal cycler
(GeneAmp PCR System 9700; Applied Biosystems). PCR
products were purified with Wizard SV Gel and PCR Clean-up
System (Promega) or treated with Exonuclease I and Antarctic
Phosphatase (New England Biolabs). Direct sequencing was
performed using the BigDye Terminator v3.1 Cycle Sequencing
Kit on an ABI3100 autosequencer (Applied Biosystems). For
Japanese arRP patients, all 44 exons, including 3 non-coding
exons (exons 1–3) that cover the 59 untranslated region and 41
coding exons (exons 4–44), were analyzed in both sense and
antisense directions. For Japanese adRP and LCA patients, and
Korean arRP patients, parts of exons 26 and 44 were analyzed
(Table S1).
Assessment of pathogenicity
A sequence variant was considered pathogenic if it represented
a truncating mutation (nonsense or frameshift), large-scale deletion
mutation, or missense mutation affecting a conserved amino acid
residue and did not appear in control samples (number of alleles
studied #400) and/or in a public SNP database (http://www.
ncbi.nlm.nih.gov/projects/SNP/). Particularly, missense muta-
tions were considered pathogenic if found together with a second
variant, especially if it was truncating. As reference data, we
employed 4 computational algorithms to evaluate the pathogenic-
ity of missense mutations: SIFT (http://sift.jcvi.org/www/SIFT_
seq_submit2.html), PolyPhen2 (http://genetics.bwh.harvard.edu/
pph2/), PMut (http://mmb.pcb.ub.es/PMut/), and SNAP
(http://rostlab.org/services/snap/).
Results
Mutation analysis
Mutation analysis of EYS in 100 unrelated Japanese patients
revealed 7 very likely pathogenic mutations in 18 patients (18%).
Of these 18 patients, a second mutant allele could not be detected
in 9 patients. The very likely pathogenic mutations consisted of 3
truncating mutations, 1 deletion mutation, 2 missense mutations,
and 1 previously described mutation (Fig. 1, Table 1, and Table 2).
In addition, we also identified 6 possible pathogenic mutations in 8
separate patients (Table 1 and Table 2).
A novel truncating insertion, c.4957_4958insA, was detected in
12 patients and accounted for 15 of the 35 mutated alleles detected
(42.9%) (Table 1 and Table 2). Three patients were homozygous
for the c.4957_4958insA mutation, and the other 9 patients were
heterozygous. Of the latter, 3 patients showed the second mutation
while 6 did not. This insertion creates a frameshift mutation that
predicts a premature stop at codon 1654 (p.S1653KfsX2). A novel
truncating nonsense mutation c.8868C.A (p.Y2956X) was
identified in 4 patients and accounted for 5 of the 35 mutated
alleles detected (14.3%). Thus, these 2 novel truncating mutations
were identified in 16 separate patients, resulting in a very high
frequency of the 2 mutations in Japanese arRP patients.
Two Major Causative Mutations in Japanese arRP
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31036Families with very likely pathogenic mutations and both
alleles affected
Nine of the 18 patients bearing very likely pathogenic mutations
appeared to have both alleles affected, suggesting that they
received one mutated allele from each unaffected parent (Table 1
and Table 2). In 4 patients (RP3H, RP48K, RP56K, and RP81K),
segregation analysis was performed, and the 2 pathogenic alleles
were considered to be on different chromosomes (Fig. 2).
1.In RP3H, proband (II-6) was homozygous for
c.4957_4958insA. The mutation co-segregated with the
phenotype: the unaffected brother (II-4) demonstrated wild-
type alleles, while the affected brother (II-5) was homozygous
for the mutation.
2.In RP48K, proband (II-1) was homozygous for
c.4957_4958insA. The unaffected brother (II-2) was heterozy-
gous for the mutation.
3. In RP56K, proband (II-1) was compound heterozygous for
c.4957_4958insA and missense mutation c.8351T.G
(p.L2784R). The mutation co-segregated with the phenotype:
the affected brother (II-2) also showed both mutations, while the
unaffected brother (II-3) was heterozygous for c.4957_4958insA.
Figure 1. Electropherograms of the 6 likely pathogenic EYS mutations. Partial sequence of the EYS gene showing the normal control
sequences (A-1 through F-1), heterozygous mutation sequences (A-2 through F-2), and homozygous mutation sequences (A-3 and C-3). Deduced
amino acids are indicated under the sequence trace. The mutation location is indicated either by an arrow (for a nucleotide change) or a horizontal
line (to show 2 nucleotides between which the insertion occurred). (A) c.4957_4958insA; p.S1653KfsX2 (Exon 26), (B) c.6557G.A; p.G2186E (Exon 32),
(C) c.8868C.A; p.Y2956X (Exon 44), (D) c.8351T.G; p.L2784R (Exon 44), (E) c.7793G.A; p.G2598D (Exon 40), (F) c.2522_2523insA; p.Y841X (Exon 16).
doi:10.1371/journal.pone.0031036.g001
Two Major Causative Mutations in Japanese arRP
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e310364. In RP81K, proband (II-5) was compound heterozygous for
truncating insertion c.2522_2523insA (p.Y841X) and missense
mutation c.6557G.A (p.G2186E). This insertion results in
premature termination of the encoded protein at codon 841
(p.Y841X). Missense mutation c.6557G.A has been previous-
ly reported as disease causing in one Korean/American and
one Chinese patient [3,6]. The unaffected mother (I-2) was
heterozygous for c.2522_2523insA, while the unaffected sister
(II-6) was heterozygous for c.6557G.A.
For the other patients, segregation analysis could not be performed
due to difficulties in collecting samples from the families of patients
(Table 1). RP54K and RP35K were homozygous for truncating
mutation c.4957_4958insA and c.8868C.A, respectively. RP21H was
homozygous for deletion in exon 32, an in-frame deletion that results in
the replacement of amino acids from D2142 to S2191 with G2142
(p.D2142_S2191delinsG) and disrupts the second laminin G domain
(Fig. 3). RP44K and RP87N were heterozygous for truncating and
missense mutations, c.4957_4958insA/c.6657G.A (p.G2186E) and
Table 1. Mutation spectrum of the EYS gene in Japanese families.
Family
ID
Nucleotide
change Predicted effect Domain
a
Location in
gene
Type of
change Reference
Families with very likely pathogenic mutations and both alleles affected
RP3H
b c.4957_4958insA/
c.4957_4958insA
p.S1653KfsX2/
p.S1653KfsX2
Close to coiled-coil/
Close to coiled-coil
Exon 26/Exon 26 Homozygous This study
RP48K
b c.4957_4958insA/
c.4957_4958insA
p.S1653KfsX2/
p.S1653KfsX2
Close to coiled-coil/
Close to coiled-coil
Exon 26/Exon 26 Homozygous This study
RP54K c.4957_4958insA/
c.4957_4958insA
p.S1653KfsX2/
p.S1653KfsX2
Close to coiled-coil/
Close to coiled-coil
Exon 26/Exon 26 Homozygous This study
RP44K c.4957_4958insA/
c.6557G.A
p.S1653KfsX2/
p.G2186E
Close to coiled-coil/
Laminin G
Exon 26/Exon 32 Heterozygous/
Heterozygous
This study/Abd El-Aziz et al., 2010;
Littink et al., 2010; This study
RP56K
b c.4957_4958insA/
c.8351T.G
p.S1653KfsX2/
p.L2784R
Close to coiled-coil/
Laminin G
Exon 26/Exon 44 Compound
Heterozygous
This study
RP87N c.4957_4958insA/
c.7793G.A
p.S1653KfsX2/
p.G2598D
Close to coiled-coil/
Close to Laminin G
Exon 26/Exon 40 Heterozygous/
Heterozygous
This study
RP81K
b c.2522_2523insA/
c.6557G.A
p.Y841X/p.G2186E EGF/Laminin G Exon 16/Exon 32 Compound
Heterozygous
This study/Abd El-Aziz et al., 2010;
Littink et al., 2010; This study
RP21H deletion exon32/
deletion exon32
p.D2142_S2191delinsG/
p.D2142_S2191delinsG
Laminin G/Laminin G Exon 32/Exon 32 Homozygous This study
RP35K c.8868C.A/c.8868C.A p.Y2956X/p.Y2956X EGF/EGF Exon 44/Exon 44 Homozygous This study
Families with single very likely pathogenic mutations
RP1H c.4957_4958insA p.S1653KfsX2 Close to coiled-coil Exon 26 Heterozygous This study
RP6H c.4957_4958insA p.S1653KfsX2 Close to coiled-coil Exon 26 Heterozygous This study
RP12H c.4957_4958insA p.S1653KfsX2 Close to coiled-coil Exon 26 Heterozygous This study
RP51K c.4957_4958insA p.S1653KfsX2 Close to coiled-coil Exon 26 Heterozygous This study
RP96H c.4957_4958insA p.S1653KfsX2 Close to coiled-coil Exon 26 Heterozygous This study
RP100N c.4957_4958insA p.S1653KfsX2 Close to coiled-coil Exon 26 Heterozygous This study
RP8H c.8868C.A p.Y2956X EGF Exon 44 Heterozygous This study
RP25H c.8868C.A p.Y2956X EGF Exon 44 Heterozygous This study
RP80K
b c.8868C.A p.Y2956X EGF Exon 44 Heterozygous This study
Families with single possible pathogenic mutations
RP4H c.9272T.C p.I3091T Laminin G Exon 44 Heterozygous This study
RP9H c.8875C.A p.L2959M EGF Exon 44 Heterozygous This study
RP49K c.9272T.C p.I3091T Laminin G Exon 44 Heterozygous This study
RP53K c.5884A.G p.T1962A Laminin G Exon 28 Heterozygous This study
RP55K c.9272T.C p.I3091T Laminin G Exon 44 Heterozygous This study
RP74K c.5404C.T p.L1802F Close to Laminin G Exon 26 Heterozygous This study
RP79K c.77G.A p.R26Q Close to signal
peptide cleavage site
Exon 4 Heterozygous This study
RP83K c.2923T.C p.C975R EGF Exon 19 Heterozygous This study
Nucleotide numbering reflects cDNA numbering with +1 corresponding to the A of the ATG translation initiation codon in the reference sequence FM209056, according
to the nomenclature recommended by the Human Genome Variation Society (www.hgvs.org/mutnomen). The initiation codon is codon 1. None of these 13 mutations
were found in the Japanese controls.
aEYS has a signal peptide, a putative coiled-coil, 29 EGF, and 5 Laminin G domains. See Fig. 3.
bSegregation analysis has been performed. See Fig. 2.
In RP56K and RP81K, 2 pathogenic alleles were considered to be on different chromosomes (compound heterozygous). See Fig. 2.
doi:10.1371/journal.pone.0031036.t001
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e31036c.4957_4958insA/c.7793T.G (p.G2598D), respectively. None of these
7 very likely pathogenic mutations were found in the Japanese controls.
Families with single novel very likely pathogenic
mutations
The rest of the patients comprising the group with very likely
pathogenic mutations presented only single truncating mutations
(Table 1 and Table 2). RP1H, RP6H, RP12H, RP51H, RP96H,
and RP100N were heterozygous for c.4957_4958insA. RP8H,
RP25H, and RP80K were heterozygous for c.8868C.A. Se-
gregation analysis was performed in patient RP80K. The
unaffected father (I-1) demonstrated wild-type alleles, and the
unaffected mother (I-2) was heterozygous for the mutation (Fig. 2).
In RP96H, we found very likely pathogenic missense mutation
c.8923T.C (p.F2975L), which was not detected in any of the 400
control alleles. However, as c.8923T.C has been described as
rs79036642 in the dbSNP database, it was assigned to the group of
possible non-pathogenic sequence alterations (Table 3).
Families with single novel possible pathogenic mutations
A group of patients with possible pathogenic mutations had only
single missense mutations (Table 1 and Table 2). We report 6
novel missense mutations in 8 different patients (Table 1 and
Table 2), none of which were identified in the 400 Japanese
control alleles. All amino acid residues affected by these mutations
were compared with those encoded by orthologous genes of
various vertebrates (orangutan, marmoset, horse, dog, opossum,
platypus, chicken, and zebrafish) and Drosophila and found to be
highly conserved across species (Table 2). The novel missense
mutation c.2923T.C (p.C975R) was predicted to be pathogenic
by 3 different computational prediction programs (PolyPhen2,
PMut, and SNAP) (Table 2). RP4H, RP49K, and RP55K
were heterozygous for the same missense mutation c.9272T.C
(p.I3091T), which was predicted to be pathogenic by SIFT and
PolyPhen2 programs (Table 2). In addition, 54 possible non-
pathogenic sequence alterations were found, of which 9 were
previously unreported (Table 3).
Screening of the 2 truncating mutations
We focused on 2 truncating mutations, c.4957_4958insA in
exon 26 and c.8868C.A in exon 44, which were identified in 16
separate Japanese arRP patients in this study. The frequency of
the 2 mutations was very high in this Japanese arRP cohort.
However, we did not detect the 2 mutations in 19 Japanese adRP
Figure 2. Pedigrees of the families that was available for mutation analysis. Below the individuals, genotypes are presented for either
p.S1653KfsX2 (M1), p.L2784R (M2), p.Y2956X (M3), p.Y841X (M4), or p.G2186E (M5) detected to segregate with RP. M1/M1 represents homozygous
mutation. M1/+ indicates heterozygous carriers, +/+ indicates individuals carrying 2 wild-type alleles, whereas M1/M2 represents individuals
presenting both mutations as compound heterozygous. Square boxes indicate men, circles denote women, and affected individuals are pointed out
by a black symbol. Slashed symbols indicate deceased individuals. The probands are indicated with an arrow. NA denotes unavailable DNA samples.
doi:10.1371/journal.pone.0031036.g002
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PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31036patients and 28 LCA patients who were recruited and screened to
evaluate the frequency of the mutations. We also recruited 32
unrelated Korean arRP patients and screened for the 2 EYS gene
mutations. The c.4957_4958insA mutation was detected in 2
patients and accounted for 3 of 64 Korean patient alleles (4.7%).
One patient was homozygous and the other was heterozygous.
The c.8868C.A mutation was identified in 1 patient and
accounted for 1 of the 64 Korean patient alleles (1.6%).
Clinical findings
Nine Japanese patients with very likely pathogenic EYS gene
mutations in both alleles, 9 Japanese patients with single very likely
pathogenic changes, and a Korean patient with homozygous
c.4957_4958insA mutation demonstrated classic RP with mostly
night blindness as the initial symptom, followed by gradual
constriction of the visual field. The fundus displayed bone spicules
increasing in density with age and attenuated retinal vessels.
Electroretinogram responses were not detectable, consistent with
severe generalized rod-cone dysfunction. The remaining visual
field determined using Goldmann kinetic perimetry with V-4
target ranged from approximately 10u to 60u of the central and
inferior visual fields, respectively, in a 74-year-old woman
(RP100N) to complete blindness in a 54-year-old man (RP21H).
No remarkable clinical difference was observed between 9 patients
with very likely pathogenic EYS gene mutations in both alleles and
9 patients with single very likely pathogenic changes.
Discussion
This study is the first to analyze mutations in the EYS gene
among Japanese arRP patients. We detected 67 sequence
alterations in the EYS gene, of which 21 were novel. Of these, 7
were very likely pathogenic mutations, 6 were possibly pathogenic
mutations, and 54 were possible non-pathogenic sequence
alterations (Table 1, Table 2, and Table 3).
Considering only the very likely pathogenic mutations, the
minimum observed prevalence of distinct EYS gene mutations in
our study is 18% (18/100, 9 patients with 2 very likely pathogenic
mutations and 9 with only one such mutations). Additionally, if the
possible pathogenic mutations are included in the prevalence
estimation, prevalence increases to 26% (26/100, with 17 of 26
patients presenting single mutations). The estimated prevalence in
our study may be extremely high compared with those in the
previous studies [3–6]. Until recently, mutations in 34 genes have
been associated with arRP (http://www.sph.uth.tmc.edu/Retnet/).
The most frequently mutated gene is USH2A, accounting for
Figure 3. Predicted domain structure and distribution of identified EYS mutations. SMART (http://smart.embl-heidelberg.de/) and Pfam
(http://pfam.sanger.ac.uk/) were used to search protein functional domains. A coiled-coil domain identified by Barraga ´n et al. (2010) between the
EGF-like domain and laminin G domain was also indicated. Novel very likely pathogenic mutations, novel possible pathogenic mutations, and a
previously described mutation are shown in bold, normal, and italic type, respectively. Six out of 9 missense mutations were found in the EGF or
laminin G domains. Furthermore, 7 were located in the latter half of the protein between the putative coiled-coil region and C-terminus.
doi:10.1371/journal.pone.0031036.g003
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PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e31036Table 3. Summary of the possible non-pathogenic sequence alterations in the EYS gene identified in this study.
Gene
exon Nucleotide change
Predicted
effect
Conservation in hu/
o/m/ho/d/op/p/c/z/dr
a
Patient
frequency
Control
frequency SNP ID Reference
Exon 1 c.-500A.G 13/200 rs1490127 Abd El-Aziz et al., 2010
Exon 4 c.334G.A p.V112I V/I/I/I/I/I/-/-/-/E 1/200 0/192 rs112609906
c.359C.T p.T120M T/T/T/T/T/A/-/-/-/I 60/200 rs12193967 Audoetal.,2010; Abd El-Aziz et al., 2010
c.525_527delGGA p.176delE E/E/E/E/E/A/-/-/-/G 1/200 1/192 This study
Intron 5 c.863-23_863-22insTT 53/200 rs34154043 Abd El-Aziz et al., 2010
c.863-23_863-22insTTT 44/200 This study
Exon 6 c.1005G.T p.E335D E/E/D/-/-/-/-/-/-/- 3/200 rs80095433
Exon 7 c.1146T.C p.N382N N/N/T/-/-/-/-/-/-/- 97/200 rs974110 Audoetal.,2010; Abd El-Aziz et al., 2010
Intron 8 c.1300-3C.T 117/200 rs1936439 Audo et al., 2010; Abd El-Aziz et al., 2010
Exon 9 c.1382G.A p.C461Y C/C/Y/-/-/-/-/-/-/- 8/200 4/192 rs76754818 Littink et al., 2010
Intron 9 c.1599+96A.C 200/200 rs1502963 Abd El-Aziz et al., 2010
Intron 10 c.1600-38G.A 12/200 rs1502965 Abd El-Aziz et al., 2010
Exon 11 c.1712A.G p.Q571R Q/Q/Q/-/-/-/-/-/-/- 26/200 rs61753610 Audo I et al., 2010
Exon 12 c.1809C.T p.V603V V/V/V/-/-/-/-/-/-/- 178/200 rs9345601 Audoetal.,2010; Abd El-Aziz et al., 2010
c.1891G.A p.G631S G/S/E/C/C/-/-/-/-/- 178/200 rs9342464 Audoetal.,2010; Abd El-Aziz et al., 2010
c.1922A.T p.E641V E/E/E/E/E/-/-/-/-/- 18/200 rs17411795 Audoetal.,2010; Abd El-Aziz et al., 2010
c.1985G.T p.R662M R/R/R/S/S/-/-/-/-/- 8/200 3/96 This study
Intron 12 c.2023+6_2023+7insT 175/200 rs67504324
c.2024-14C.T 3/200 rs45628235
Intron 15 c.2382-26C.G 106/200 rs9445437
Exon 16 c.2490T.C p.P830P P/P/P/P/P/P/P/Q/P/- 2/200 1/392 This study
c.2528G.A p.G843E G/G/G/G/G/G/G/G/A/G 16/200 9/192 rs74419361
c.2555T.C p.L852P L/P/P/-/S/P/S/P/-/E 106/200 rs9294631 Audoetal.,2010; Abd El-Aziz et al., 2010
Intron 18 c.2846+52_2846+
53insTAAT
120/200 rs66504228 Abd El-Aziz et al., 2010
c.2847-24C.T 178/200 rs7743515
Exon 19 c.2980C.G p.P994A P/P/P/-/-/-/-/-/-/- 3/200 2/192 This study
Intron 22 c.3444-5C.T 69/200 rs9445051 Audo et al., 2010; Abd El-Aziz et al., 2010
Intron 23 c.3568+60delA 1/200 This study
Exon 25 c.3787A.G p.I1263V I/V/V/V/V/-/-/-/-/I 36/200 rs17404123 Audoetal.,2010; Abd El-Aziz et al., 2010
c.3809T.G p.V1270G V/V/V/V/V/-/-/-/-/P 1/200 1/192 This study
Intron 25 c.3877+17_
22delAGATA
36/200 Barraga ´n I et al., 2010
Exon 26 c.3906C.T p.H1302H H/H/H/H/H/-/-/-/-/S 10/200 rs12663916 Audoetal.,2010; Abd El-Aziz et al., 2010
c.3936A.G p.T1312T T/A/T/A/A/-/-/-/-/S 10/200 rs12662610 Audoetal.,2010; Abd El-Aziz et al., 2010
c.3973C.G p.Q1325E Q/E/K/K/K/-/-/-/-/S 12/200 rs12663622 Audoetal.,2010; Abd El-Aziz et al., 2010
c.4026C.T p.S1342S S/S/S/S/S/-/-/-/-/A 10/200 rs12663619 Audoetal.,2010; Abd El-Aziz et al., 2010
c.4081A.G p.I1361V I/I/T/V/V/-/-/-/-/S 12/200 rs17403955 Audoetal.,2010; Abd El-Aziz et al., 2010
c.4256T.C p.L1419S L/S/S/S/S/L/S/V/Q/V 137/200 rs624851 Audoetal.,2010; Abd El-Aziz et al., 2010
c.4352T.C p.I1451T I/T/T/K/K/-/-/-/-/T 13/200 rs62415828 Audoetal.,2010; Abd El-Aziz et al., 2010
c.4543C.T p.R1515W R/R/R/R/R/-/-/-/-/H 36/200 rs62415827 Audoetal.,2010; Abd El-Aziz et al., 2010
c.4549A.G p.S1517G S/G/D/T/T/-/-/-/-/H 36/200 rs62415826 Audoetal.,2010; Abd El-Aziz et al., 2010
c.4593G.A p.E1531E E/E/E/E/E/-/-/-/-/Q 36/200 rs62415825 Audoetal.,2010; Abd El-Aziz et al., 2010
c.5244A.C p.L1748F L/L/L/L/L/-/-/-/-/F 8/200 rs57312007 Audo I et al., 2010; Littink et al., 2010
c.5617C.G p.L1873V L/L/L/P/P/-/-/-/-/I 38/200 rs16895517 Audo I et al., 2010
Exon 27 c.5705A.T p.N1902I N/N/N/N/N/P/-/R/-/A 90/200 rs9353806 Audoetal.,2010; Abd El-Aziz et al., 2010
Intron 28 c.5928-35T.C 118/200 rs587278 Abd El-Aziz et al., 2010
Intron 29 c.6078+68A.G 81/200 rs36133910 Abd El-Aziz et al., 2010
c.6079-4_6079-3delTC 87/200 rs35395170 Audo I et al., 2010
Intron 34 c.6834+61T.G 60/200 rs66502009 Abd El-Aziz et al., 2010
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PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31036approximately 7% of arRP cases [9,10], whereas most other genes
contribute to only 1% to 2% of arRP cases [11]. The estimated
prevalence of very likely and possible pathogenic mutations of the
EYS gene in our study was 26%, suggesting its major involvement in
the pathogenesis of arRP in the Japanese population.
We found that 16% of Japanese arRP patients displayed at least
one c.4957_4958insA or c.8868C.A mutation, which accounted
for 57.1% (15+5/35) of the mutated alleles. Thus, these mutations
seem to be frequent among Japanese arRP patients. Previous
studies employing Indonesian, Pakistani, Chinese, Israeli, Spanish,
French, British, Dutch, and Palestinian RP patient populations
have not detected them [3–6,12–15]. Since the Japanese were
divided into small semi-closed population groups among which
intercommunication was quite less until the mid-20
th century,
obvious or latent consanguineous marriages were carried out more
frequently, leading to relatively high inbreeding levels in those
populations. The frequency of the c.4957_4958insA and
c.8868C.A mutations may result from a founder effect like that
of the 2299delG USH2A gene mutation, which accounts for 44%
of disease alleles in Danish and Norwegian patients with Usher
syndrome type II [16].
We detected 13 different very likely and possible pathogenic
mutations. Three were truncating mutations and accounted for
60% (21/35) of mutated alleles. Likewise, previous studies
reported that most pathogenic mutations were truncated type
(nonsense, deletion, insertion, or splicing) [3–6,12–15]. Further-
more, c.6557G.A was the only mutation that was common
between the Japanese and other populations. This mutation has
been found in Korean/American and Chinese patients [3,6].
These results indicate that the EYS gene mutation spectrum
among Japanese patients largely differs from that among the
previously mentioned non-Asian populations. The Japanese and
Korean mutation spectrum may resemble each other, but an
accurate comparison could not be made, because further EYS
gene analysis of Korean RP patients is required to clarify this
possibility.
A second mutant allele could not be detected by direct
sequencing in 17 of 26 patients in our study. Previous studies
reported 7 of 10 [3] and 9 of 17 [5] patients with heterozygous EYS
gene mutation, implying that this finding could be due to relatively
large heterozygous deletions [15]. The second mutation in these
families may also have been located within the gene regulatory
elements or unknown exons including alternative splicing areas.
Although rare, a single EYS mutation in combination with another
mutation on a second gene could also explain this phenotype [3].
The c.4957_4958insA and c.8868C.A mutations were not
detected in Japanese patients with adRP or with LCA. Abd El-
Aziz et al. reported that EYS gene mutation screening did not
reveal any pathogenic mutations in 95 British and Chinese adRP
patients [3]. Bandah-Rosenfeld et al. reported that no mutation
was found in 2 Oriental Jewish and Israeli Muslim LCA patients
who had a large homozygous region harboring the EYS gene [12].
Although further analysis of all EYS gene exons is required, EYS
gene mutations may not be detected in Japanese patients with
adRP and LCA. The c.4957_4958insA and c.8868C.A muta-
tions were also detected in Korean patients with arRP and
accounted for 6.3% (4/64 alleles) of the disease alleles. Similar to
Japanese arRP results, the c.4957_4958insA mutation was more
frequently detected than the c.8868C.A mutation. The fact that
both c.4957_4958insA and c.8868C.A mutations were also
detected in Korean patients suggests the possibility that the
mutations occurred in an ancient common ancestor and spread
throughout East Asia.
RP is a highly heterogeneous disease, with a reported
prevalence rate of 1 in 4,000–8,000 people in Japan. Given the
population of Japan, approximately a 100 million, the number of
patients with RP can be estimated to be 12,500–25,000. The
relative frequencies of RP inheritance patterns in Japanese patients
were estimated as 25.2% for autosomal recessive, 16.9% for
autosomal dominant, 1.6% for X-linked, and 56.3% for simplex,
indicating that most Japanese RP patients represent arRP or
isolated cases [17]. Autosomal recessive and simplex cases account
over 80% of RP cases in Japan (approximately 10,000–20,000
people). Our results indicate that c.4957_4958insA and
c.8868C.A mutations are possibly present in 1,600–3,200
Japanese patients with RP. These 2 novel mutations will be very
useful for genetic diagnosis and counseling, and analysis of the
mutated proteins may be helpful in the development of effective
therapies for RP in Japan and Korea.
In conclusion, mutation screening of the EYS gene in 100
Japanese patients revealed 13 different pathogenic mutations,
confirming that the mutation spectrum in Japanese patients differs
from the previously reported spectrum in patients of non-Asian
populations. Among these 13 mutations, 2 truncating mutations,
c.4957_4958insA and c.8868C.A, were detected in at least one
mutated allele in 16% of Japanese arRP patients and may be the
Gene
exon Nucleotide change
Predicted
effect
Conservation in hu/
o/m/ho/d/op/p/c/z/dr
a
Patient
frequency
Control
frequency SNP ID Reference
Exon 35 c.6977G.A p.R2326Q R/R/R/L/L/L/L/L/I/L 95/200 rs4710457 Audo et al., 2010; Abd El-Aziz et al.,
2010
Exon 37 c.7394C.G p.T2465S T/T/T/T/T/T/T/T/S/F 8/200 2/176 This study
Exon 39 c.7666A.T p.S2556C S/S/S/S/S/N/S/H/E/E 57/200 rs66462731 Audo et al., 2010; Abd El-Aziz et al.,
2010; Barraga ´n et al., 2010; Littink et
al., 2010
Intron 41 c.8071+84T.G 53/200 rs4710257 Abd El-Aziz et al., 2010
Exon 44 c.8923T.C p.F2975L F/F/F/F/F/F/F/F/-/K 1/200 0/400 rs79036642
c.9300A.G p.L3100L L/L/L/L/L/L/L/L/V/I 4/200 2/192 This study
Fifty-four sequence alterations were identified in 100 patients. These alterations were predicted to be non-pathogenic for various reasons. Some have been reported as
polymorphisms in previous reports. Newly identified alterations within the exons, except for c.334G.A and c.8923T.C, were also found in the control chromosome.
The hyphen (-) indicates that genomic sequence of corresponding region in the species was reported to be unknown [5].
ahu/o/m/ho/d/op/p/c/z/dr denotes Human/Orangutan/Marmoset/Horse/Dog/Opossum/Platypus/Chicken/Zebrafish/Drosophila EYS orthologs, respectively.
doi:10.1371/journal.pone.0031036.t003
Table 3. Cont.
Two Major Causative Mutations in Japanese arRP
PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e31036most frequent mutations causing RP in the Japanese populations.
Screening for c.4957_4958insA and c.8868C.A mutations in the
EYS gene is, therefore, very effective for the genetic testing and
counseling of RP patients in Japan. Further analysis is necessary to
obtain a more precise mutation spectrum and to identify other
frequent mutations in other East Asian populations.
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